In the Diabetes Complications and Control Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC), the extensive health benefits of intensive insulin therapy were highlighted, reporting a significant 57% and 42% reduction in cardiovascular disease events and mortality, respectively, among people with T1D. The gene discussed is INS; the disease is type 1 diabetes mellitus.